None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients aged 19 years or older 2) Patients taking single or dual antiplatelet drugs i) Those taking a single P2Y12 inhibitor ii) Those taking both P2Y12 inhibitor + Aspirin 3) Patients who need endoscopic resection (mucosal resection, cold snare polypectomy) for colon neoplasia i) < 20 mm size polyp ii) Less than 10 polyps 4) Patients who stopped taking P2Y12 inhibitor for more than 5 days before colonoscopy
Exclusion criteria
Exclusion criteria: 1) Patients under the age of 18 2) Those with a history of massive bleeding and hemostasis disorders 3) Cases diagnosed with acute coronary syndrome within 3 months 4) Cases where endoscopy cannot be performed due to unconsciousness or anatomical reasons 5) If consent cannot be obtained 6) Others who are judged by the
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Endpoints and Methods: To compare the incidence of delayed bleeding after endoscopic polypectomy | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints and methods: Immediate bleeding and cardiovascular stability after endoscopic resection are evaluated. | — |
Countries
Korea, Republic of
Contacts
Yonsei University Yongin Severance Hospital